Skip to search.
 BSE Down 0.42% NSE Down 0.59%

More On AEZS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Aeterna Zentaris Inc. (AEZS)

-NasdaqCM
0.57 0.00(0.00%) 25 Apr 1:30AM
Add to Portfolio
Prev Close:0.57
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:1.43
Beta:2.51
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.48 - 1.54
Volume:0
Avg Vol (3m):2,061,040
Market Cap:51.26M
P/E (ttm):N/A
EPS (ttm):-0.28
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for AEZS at this time.

Comparison

Symbol% ChgMkt Cap
AEZS 0.00%51.26M
CELG 0.00%95.04B
ENMD 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4,659.57
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.34
Quarterly EPS Est (Mar-15) :-0.10
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback